Association of gut microbiome signatures with iron metabolism response to roxadustat in peritoneal dialysis patients with anemia: a cross-sectional study
BackgroundAnemia in chronic kidney disease (CKD) is associated with increased cardiovascular risk, impaired quality of life, and reduced survival. Roxadustat, a hypoxia-inducible factor prolyl hydroxylase inhibitor (HIF-PHI), has demonstrated non-inferior efficacy to erythropoiesis-stimulating agent...
Bewaard in:
| Hoofdauteurs: | , , , , , |
|---|---|
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
Frontiers Media S.A.
2026-07-01
|
| Reeks: | Frontiers in Pharmacology |
| Onderwerpen: | |
| Online toegang: | https://www.frontiersin.org/articles/10.3389/fphar.2026.1862547/full |
| Tags: |
Geen labels, Wees de eerste die dit record labelt!
|